Cited by — Optimizing the ER Cutoff in HER2 ‐Positive Breast Cancer: ER ≥ 50% Predicts Low pCR Rates and Resistance to Antibody‐Drug Conjugates in the Neoadjuvant Setting | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Optimizing the ER Cutoff in HER2 ‐Positive Breast Cancer: ER ≥ 50% Predicts Low pCR Rates and Resistance to Antibody‐Drug Conjugates in the Neoadjuvant Setting.
No admitted local citation edges point to this work yet.
